DK1084261T3 - Rekombinant vaccine mod venezuelansk hesteencephalitis - Google Patents

Rekombinant vaccine mod venezuelansk hesteencephalitis

Info

Publication number
DK1084261T3
DK1084261T3 DK99920967T DK99920967T DK1084261T3 DK 1084261 T3 DK1084261 T3 DK 1084261T3 DK 99920967 T DK99920967 T DK 99920967T DK 99920967 T DK99920967 T DK 99920967T DK 1084261 T3 DK1084261 T3 DK 1084261T3
Authority
DK
Denmark
Prior art keywords
vaccine against
equine encephalitis
venezuelan equine
recombinant vaccine
against venezuelan
Prior art date
Application number
DK99920967T
Other languages
English (en)
Inventor
Alice Marie Bennett
Original Assignee
Secr Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Secr Defence filed Critical Secr Defence
Application granted granted Critical
Publication of DK1084261T3 publication Critical patent/DK1084261T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK99920967T 1998-05-29 1999-05-05 Rekombinant vaccine mod venezuelansk hesteencephalitis DK1084261T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9811433A GB2337755B (en) 1998-05-29 1998-05-29 Virus vaccine
EP99920967A EP1084261B8 (en) 1998-05-29 1999-05-05 Recombinant venezuelan equine encephalitis virus vaccine

Publications (1)

Publication Number Publication Date
DK1084261T3 true DK1084261T3 (da) 2005-01-17

Family

ID=10832820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99920967T DK1084261T3 (da) 1998-05-29 1999-05-05 Rekombinant vaccine mod venezuelansk hesteencephalitis

Country Status (14)

Country Link
US (2) US6936257B1 (da)
EP (1) EP1084261B8 (da)
AR (1) AR020080A1 (da)
AT (1) ATE275631T1 (da)
AU (1) AU3834999A (da)
BR (1) BR9910814A (da)
CA (1) CA2329133C (da)
DE (1) DE69920011T2 (da)
DK (1) DK1084261T3 (da)
ES (1) ES2224655T3 (da)
GB (1) GB2337755B (da)
MX (1) MXPA00011708A (da)
PT (1) PT1084261E (da)
WO (1) WO1999063098A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine
CA2401974C (en) 2000-03-02 2013-07-02 Emory University Dna expression vectors and methods of use
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
DE60234018D1 (de) * 2001-03-08 2009-11-26 Univ Emory Mva-exprimierende modifizierte hiv-envelope-, gag-, und pol-gene
DE602004000851T2 (de) * 2003-10-30 2007-05-16 Avago Technologies General Ip (Singapore) Pte. Ltd. Akustisch gekoppelter Dünnschicht-Transformator mit zwei piezoelektrischen Elementen, welche entgegengesetzte C-Axen Orientierung besitzten
WO2008101349A1 (en) * 2007-02-23 2008-08-28 Her Majesty The Queen, In Right Of Canada, As Repesented By The Minister Of National Defence Recombinant viral vectors for prevention and protection against alphavirus infection
JP5908397B2 (ja) * 2009-06-09 2016-04-26 デフィルス、インコーポレイテッドＤｅｆｙｒｕｓ， Ｉｎｃ． 病原体感染を予防又は治療するためのインターフェロン投与
CA2826920A1 (en) 2011-02-15 2012-08-23 Immune Design Corp. Methods for enhancing immunogen specific immune responses by vectored vaccines
MX350795B (es) 2011-04-08 2017-09-19 Inmune Design Corp Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
WO2013151567A1 (en) * 2012-04-04 2013-10-10 The United States Of America, As Represented By The Secretary Of The Army, On Behalf Of U.S. Army Medical Research Institute Of Infectious Diseases Equine encephalitis virus vaccines and methods of using thereof
LT2850431T (lt) 2012-05-16 2018-06-25 Immune Design Corp. Vakcinos, skirtos hsv-2
ES2655442T3 (es) * 2012-11-05 2018-02-20 Regeneron Pharmaceuticals, Inc. Animales no humanos modificados genéticamente y métodos de uso de los mismos
EP3542816A1 (en) 2014-02-14 2019-09-25 Immune Design Corp. Immunotherapy of cancer through combination of local and systemic immune stimulation
CA2955015A1 (en) 2014-07-15 2016-01-21 Immune Design Corp. Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
ES2921605T3 (es) 2016-01-29 2022-08-30 Bavarian Nordic As Vacuna contra el virus de la encefalitis equina basada en el virus de la variolovacuna modificado Ankara (VMA) recombinante
KR20230051602A (ko) 2016-04-15 2023-04-18 알파인 이뮨 사이언시즈, 인코포레이티드 Icos 리간드 변이체 면역조절 단백질 및 그의 용도
NZ746934A (en) 2016-04-15 2023-11-24 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
CN110088127A (zh) 2016-07-28 2019-08-02 高山免疫科学股份有限公司 Cd155变体免疫调节蛋白及其用途
US11834490B2 (en) 2016-07-28 2023-12-05 Alpine Immune Sciences, Inc. CD112 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
WO2018170026A2 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
DK3596116T5 (da) 2017-03-16 2024-09-02 Alpine Immune Sciences Inc Variante immunmodulatoriske pd-l1-proteiner og anvendelser deraf
JP2020511144A (ja) 2017-03-16 2020-04-16 アルパイン イミューン サイエンシズ インコーポレイテッド Ｐｄ−ｌ２バリアント免疫調節タンパク質及びその使用
JP7291398B2 (ja) 2017-03-30 2023-06-15 ザ ユニバーシティー オブ クイーンズランド キメラ分子およびその使用
EP4400174A3 (en) 2017-09-01 2024-10-23 The Francis Crick Institute Limited Immunoregulatory molecules and uses therefor
EP4442268A2 (en) 2017-10-10 2024-10-09 Alpine Immune Sciences, Inc. Ctla-4 variant immunomodulatory proteins and uses thereof
US20200283500A1 (en) 2017-10-18 2020-09-10 Alpine Immune Sciences, Inc. Variant icos ligand immunomodulatory proteins and related compositions and methods
WO2019136179A1 (en) 2018-01-03 2019-07-11 Alpine Immune Sciences, Inc. Multi-domain immunomodulatory proteins and methods of use thereof
WO2019241758A1 (en) 2018-06-15 2019-12-19 Alpine Immune Sciences, Inc. Pd-1 variant immunomodulatory proteins and uses thereof
AU2019345151A1 (en) 2018-09-19 2021-04-29 Alpine Immune Sciences, Inc. Methods and uses of variant CD80 fusion proteins and related constructs
AU2019389151A1 (en) 2018-11-30 2021-06-10 Alpine Immune Sciences, Inc. CD86 variant immunomodulatory proteins and uses thereof
BR112021020447A2 (pt) 2019-04-17 2022-05-17 Alpine Immune Sciences Inc Métodos e usos de proteínas de fusão de ligante icos variante (icosl)
CN115812077A (zh) 2020-05-08 2023-03-17 高山免疫科学股份有限公司 April和baff抑制性免疫调节蛋白及其使用方法
PE20240641A1 (es) 2021-05-07 2024-04-04 Alpine Immune Sciences Inc Metodos de dosificacion y tratamiento con una proteina inmunomoduladora de fusion taci-fc
WO2023172883A1 (en) 2022-03-07 2023-09-14 Alpine Immune Sciences, Inc. Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related methods and uses
WO2024077018A2 (en) 2022-10-04 2024-04-11 Alpine Immune Sciences, Inc. Methods and uses of taci-fc fusion immunomodulatory protein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185440A (en) * 1989-06-20 1993-02-09 North Carolina State University cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof
US5505947A (en) * 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
US6261570B1 (en) * 1997-05-20 2001-07-17 The United States Of America As Represented By The Secretary Of The Army Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine

Also Published As

Publication number Publication date
GB9811433D0 (en) 1998-07-22
WO1999063098A1 (en) 1999-12-09
DE69920011D1 (de) 2004-10-14
US6936257B1 (en) 2005-08-30
CA2329133C (en) 2011-07-12
EP1084261B1 (en) 2004-09-08
PT1084261E (pt) 2005-01-31
AR020080A1 (es) 2002-04-10
AU3834999A (en) 1999-12-20
GB2337755A (en) 1999-12-01
DE69920011T2 (de) 2005-09-15
CA2329133A1 (en) 1999-12-09
BR9910814A (pt) 2001-02-13
ATE275631T1 (de) 2004-09-15
GB2337755B (en) 2003-10-29
EP1084261A1 (en) 2001-03-21
ES2224655T3 (es) 2005-03-01
MXPA00011708A (es) 2005-10-13
USRE41745E1 (en) 2010-09-21
EP1084261B8 (en) 2004-12-15

Similar Documents

Publication Publication Date Title
DK1084261T3 (da) Rekombinant vaccine mod venezuelansk hesteencephalitis
DK1410805T3 (da) Vaccine mod HPV
NO20004758L (no) Vaksinesammensetning
NO20006191D0 (no) Vaksine
DE60025890D1 (de) Verbesserter Druckkopf
DE60043733D1 (de) Paketauthentifizierung
NO20003934L (no) Oksydkatalysatorer
DE60037189D1 (de) Rekombinante, natrium-jodid symporter-kodierende adenoviren
IS5694A (is) Bóluefni
IT247655Y1 (it) Protettore labiale.
DK1180041T4 (da) Vaccine mod ISA-virus
DE59904378D1 (de) Umlenkeinrichtung
NO20013933D0 (no) Peptider
ATE431415T1 (de) Hiv impfstoff
IT1292534B1 (it) Procedimento per preparare e confezionare wuerstel.
ES1037494Y (es) Sobre perfeccionado.
ES1037044Y (es) Sobre perfeccionado.
ES1034808Y (es) Sobre de envio perfeccionado.
ITMI981384A0 (it) Vaccino per hiv
ES1032362Y (es) Sobre perfeccionado.
ES1039493Y (es) Vaso perfeccionado.
ES1042024Y (es) Sobre perfeccionado.
ES1042470Y (es) Espada perfeccionada.
ITBO980581A0 (it) Siringa odontoiatrica .
ES1038368Y (es) Sobre reutilizable perfeccionado.